Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27692,105,2.89 [1.63-5.12],0.0002747817379349
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28271,147,3.77 [2.34-6.06],4.539811181371962e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",28013,1005,1.87 [1.54-2.28],4.3600305608231957e-10
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Candidiasis,28303,308,3.34 [2.41-4.62],4.099871693793785e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27506,2786,1.78 [1.58-2.01],5.4827348785511536e-21
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27757,2102,2.02 [1.76-2.32],3.7466435614848275e-24
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28087,1006,1.62 [1.32-1.98],2.7126514380209e-06
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28214,43,7.54 [3.44-16.50],4.376974249665593e-07
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,27021,647,2.87 [2.26-3.65],6.1800999082963865e-18
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26129,624,2.84 [2.23-3.62],3.5722092919858494e-17
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26379,175,5.61 [3.67-8.58],1.695027041912588e-15
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21088,1221,2.28 [1.91-2.72],4.9170836538242737e-20
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26134,288,2.72 [1.90-3.89],4.5623910927059545e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28255,1174,1.84 [1.53-2.22],7.431555814748266e-11
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,28365,370,2.81 [2.07-3.82],3.121964701471694e-11
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27618,610,2.46 [1.92-3.14],6.398070052941353e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28301,714,2.58 [2.07-3.23],1.003468644573581e-16
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27230,149,3.83 [2.39-6.14],2.3819462914867344e-08
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28405,33,5.06 [1.97-12.99],0.0007478599019655
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28212,625,2.72 [2.15-3.45],1.5035086544736436e-16
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28246,75,2.61 [1.29-5.25],0.0074310624645217
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28309,171,2.77 [1.74-4.41],1.841387668636687e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28295,157,2.69 [1.65-4.38],7.405398134696123e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27346,338,1.54 [1.09-2.16],0.0134876914540796
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27255,247,1.88 [1.26-2.79],0.0019906299970095
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27162,81,3.86 [2.05-7.25],2.762563960547515e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28376,53,3.00 [1.35-6.66],0.0070596285634978
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28207,1207,1.36 [1.13-1.63],0.0012512804405902
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,28361,301,1.58 [1.09-2.28],0.0147355564042418
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28328,555,1.35 [1.03-1.77],0.0303408719804532
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24535,32,3.92 [1.46-10.53],0.0068228069003399
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24541,38,3.37 [1.27-8.94],0.0145234415377582
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lung cancer and mesothelioma,21114,177,2.32 [1.47-3.66],0.000289595639282
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Lymphoid leukaemia,24532,29,3.20 [1.07-9.57],0.0372320058585463
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24556,53,7.17 [3.84-13.41],6.674082913204215e-10
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24573,70,2.21 [1.07-4.59],0.0323018499966244
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24573,70,2.33 [1.17-4.65],0.0163946874342031
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanoma in situ,24519,53,0.38 [0.17-0.89],0.0262935586307962
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24624,121,2.00 [1.12-3.57],0.0190089990238052
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24572,69,2.70 [1.31-5.57],0.0070685638618431
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,28219,143,1.85 [1.08-3.17],0.02559483274796
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28126,288,2.57 [1.79-3.69],3.137397734991841e-07
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26948,59,2.82 [1.28-6.22],0.0100120268949002
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27908,70,4.28 [2.15-8.51],3.378724873249987e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27585,2291,2.11 [1.85-2.41],1.861056758737471e-28
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27183,25,3.86 [1.24-12.00],0.0197796550728978
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,28045,36,4.48 [1.71-11.71],0.002215943508414
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27948,1059,2.48 [2.05-2.99],6.057909792048054e-21
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27948,1059,2.48 [2.05-2.99],6.057909792048054e-21
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26948,59,3.11 [1.42-6.81],0.0045376545622909
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28115,957,2.35 [1.92-2.87],1.1870843608558874e-16
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28124,115,2.26 [1.26-4.06],0.0062893526038532
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27893,55,4.85 [2.38-9.89],1.4274763280766724e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28205,196,4.10 [2.73-6.15],9.327369661038062e-12
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28325,72,2.22 [1.07-4.60],0.0311900209173395
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28174,165,4.31 [2.78-6.68],6.1853412391262e-11
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27234,76,5.13 [2.70-9.74],5.858452479573502e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24419,217,3.12 [2.11-4.62],1.3435481185694137e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26432,127,4.81 [3.05-7.59],1.3437229193886899e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26447,142,13.42 [9.96-18.08],2.819746345133815e-65
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24240,38,6.65 [3.17-13.96],5.464196119482802e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26374,72,2.99 [1.51-5.94],0.0017105839143113
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,26035,152,3.08 [1.90-4.98],4.646346352325404e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28254,173,2.93 [1.89-4.55],1.580409563987471e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27981,1679,1.66 [1.42-1.94],2.6772743982289617e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25435,1628,1.81 [1.55-2.13],2.54492020334211e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24244,42,3.36 [1.36-8.30],0.0085803718228426
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24392,190,1.76 [1.11-2.76],0.015135553875494
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24269,67,3.21 [1.56-6.63],0.0015895190296448
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26651,2449,1.55 [1.37-1.76],1.4901687296046774e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24326,124,2.90 [1.71-4.92],7.509708952170323e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24600,398,2.37 [1.74-3.21],2.9713509356846778e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28302,279,1.64 [1.12-2.40],0.0118617423879849
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24303,101,2.07 [1.13-3.81],0.0189494983489194
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24241,39,5.24 [2.24-12.27],0.0001346913599033
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27967,1338,1.93 [1.62-2.30],2.649534008505477e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24332,130,4.49 [2.81-7.19],3.63123623377239e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24370,168,3.84 [2.49-5.92],1.132910985754169e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24601,399,1.88 [1.37-2.56],7.373765016789363e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24264,62,2.68 [1.26-5.68],0.0103332007871263
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24507,305,3.40 [2.45-4.72],2.442587528489799e-13
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24506,304,2.47 [1.75-3.50],3.202423512824853e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25942,59,2.87 [1.31-6.27],0.0083705620859709
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27706,3504,1.70 [1.53-1.90],6.447059193023426e-23
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26691,62,2.39 [1.06-5.42],0.0359445663055279
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26668,39,3.42 [1.27-9.21],0.0149668426547839
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,28073,1274,1.67 [1.39-2.00],2.6224081317282653e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25124,922,2.89 [2.38-3.50],5.045468334143076e-27
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28396,140,4.45 [2.80-7.07],2.8418905039823554e-10
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28116,35,3.80 [1.49-9.69],0.0052272173613182
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26888,89,2.12 [1.10-4.09],0.0245124335524337
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26573,125,4.52 [2.76-7.41],2.240186091084027e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26490,42,3.92 [1.63-9.39],0.0022160606405596
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27974,1526,3.46 [2.98-4.01],1.4997523421967844e-60
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28156,75,2.40 [1.19-4.83],0.0144075019593869
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26162,279,2.77 [1.94-3.96],2.2221677888558653e-08
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24626,424,2.55 [1.91-3.41],2.7431737423828896e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27659,57,3.37 [1.61-7.07],0.0013046489924839
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,27100,808,1.88 [1.51-2.33],1.1627834940325977e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27706,104,2.43 [1.35-4.35],0.0029434303957679
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27708,106,3.52 [2.05-6.04],4.912866389476203e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20279,958,1.92 [1.55-2.36],1.1810464554348195e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiac arrest,19438,117,5.04 [2.89-8.78],1.1513542149369553e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25826,138,1.94 [1.14-3.30],0.0147927889877293
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25771,83,2.72 [1.41-5.24],0.0027616962203753
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,26225,537,1.71 [1.31-2.24],9.89754992350782e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27671,1390,1.79 [1.52-2.11],6.211845252822245e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26426,6178,1.66 [1.53-1.80],2.070755597389968e-33
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28288,523,2.40 [1.85-3.11],3.9293298073470096e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,27009,5027,1.76 [1.61-1.93],1.7757412511003515e-34
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",27024,5042,1.76 [1.61-1.92],2.0905890764665924e-34
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28232,59,25.81 [15.66-42.54],3.1664351127008946e-37
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22071,89,3.83 [2.03-7.22],3.352386868316407e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,28301,715,2.04 [1.62-2.58],1.344324682932312e-09
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27838,1546,1.66 [1.42-1.95],3.2123728683770904e-10
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28173,313,1.56 [1.10-2.22],0.012474634868822
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25880,192,1.85 [1.18-2.90],0.007402564833201
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28143,609,1.55 [1.21-2.00],0.0005919588225427
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26788,496,1.61 [1.22-2.12],0.0008621057538879
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28391,208,1.54 [1.00-2.38],0.0494234882360937
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Oesophageal varices,27063,41,44.49 [24.38-81.21],4.1105669284966e-35
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27747,145,3.41 [2.13-5.46],3.549415611163492e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26289,601,1.82 [1.41-2.34],3.596850384220392e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27633,47,14.99 [8.25-27.25],6.586447591520001e-19
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27950,348,2.85 [2.08-3.91],7.326968145044794e-11
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27950,161,4.64 [3.06-7.02],4.502600270479961e-13
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27811,239,1.76 [1.18-2.63],0.0054521042123068
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19574,253,1.77 [1.16-2.68],0.0075023924986159
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27787,211,2.94 [1.99-4.35],6.935077232443666e-08
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28366,338,1.69 [1.20-2.38],0.002502098156725
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25866,178,1.91 [1.20-3.06],0.0067398967249112
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27946,157,4.45 [2.91-6.78],4.3539355699034464e-12
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27693,121,2.01 [1.16-3.48],0.0125087332773887
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28166,366,1.56 [1.13-2.15],0.0072685493409695
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28139,403,1.56 [1.15-2.13],0.0045455153824861
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27611,49,2.36 [1.02-5.49],0.0455063205760992
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28243,381,5.18 [3.95-6.80],2.2091245815791678e-32
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25330,1463,1.87 [1.58-2.21],4.351739898548833e-13
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,27631,3764,1.71 [1.54-1.90],2.2068553101017202e-24
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28178,450,4.26 [3.28-5.53],9.38825645301558e-28
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25576,1709,1.84 [1.57-2.14],1.5065328731173234e-14
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,27858,1561,1.82 [1.57-2.12],2.484801010000664e-15
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25671,1804,2.26 [1.98-2.58],4.8819643664774835e-34
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Vascular dementia,28287,21,5.91 [1.75-19.97],0.0042683224124585
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Bell's palsy,26710,75,3.30 [1.68-6.47],0.0005105222685511
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27118,483,1.45 [1.08-1.95],0.013038298605491
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral cysts,28046,211,2.50 [1.64-3.81],1.943346795915036e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28322,234,1.82 [1.22-2.73],0.0035901754842092
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28392,53,3.40 [1.51-7.63],0.0030256036629504
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27912,1377,1.47 [1.24-1.74],1.2609085017713871e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27873,1697,1.72 [1.48-2.01],4.229826802811658e-12
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Generalized epilepsy,28023,51,2.89 [1.29-6.50],0.0101730554566558
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26724,89,2.01 [1.06-3.82],0.0332112175730188
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,26969,434,1.50 [1.09-2.06],0.0118582716881048
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28316,385,1.70 [1.22-2.37],0.0018117952006881
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27783,1148,1.47 [1.22-1.78],5.894995568595676e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,26942,3145,1.40 [1.25-1.57],8.647183162360177e-09
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28315,76,2.40 [1.21-4.74],0.0119112697078016
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28334,239,2.56 [1.74-3.76],1.9096077930334715e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23709,311,1.53 [1.06-2.21],0.0233836589354571
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27950,115,1.93 [1.08-3.43],0.0255019064611453
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28191,91,2.04 [1.07-3.90],0.0304480338303033
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26728,93,3.33 [1.82-6.08],9.5972421166167e-05
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,28282,447,2.00 [1.49-2.69],3.88984850543622e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,27133,598,1.40 [1.09-1.81],0.009404718910671
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28275,20,5.96 [1.73-20.56],0.0046911959221334
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28316,196,3.08 [2.03-4.66],1.0730868459477385e-07
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27950,77,2.40 [1.20-4.80],0.0134799720439192
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28276,632,1.36 [1.05-1.75],0.0199946972517516
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27744,141,1.87 [1.08-3.23],0.0255518897448693
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28394,55,2.65 [1.15-6.09],0.0220378382794448
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27621,18,4.41 [1.22-15.97],0.0237336834598878
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28212,72,2.39 [1.14-4.98],0.0202833738084992
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27679,1084,1.40 [1.15-1.70],0.0007437366714296
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28381,116,3.49 [2.01-6.04],8.7164864110196e-06
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28177,37,3.59 [1.37-9.44],0.0095712299776596
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28377,38,4.25 [1.64-11.06],0.0029760153755825
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27449,854,1.45 [1.16-1.81],0.0009783411718916
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28185,312,1.79 [1.25-2.56],0.0015165085253642
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),28005,132,2.21 [1.30-3.75],0.0034743119753858
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28196,54,2.60 [1.14-5.94],0.0237371633325983
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28318,541,1.80 [1.37-2.36],2.2982770323835493e-05
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28112,335,2.09 [1.48-2.94],2.4285011231025457e-05
PLA2G15,Phospholipase A2 group XV,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27859,82,2.60 [1.34-5.05],0.0047461485853604
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute pharyngitis,28111,84,2.08 [1.06-4.10],0.0344009805604374
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28269,242,1.57 [1.04-2.37],0.0303007542383458
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28092,65,2.35 [1.11-4.99],0.0260985171196705
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,All influenza,27062,80,3.30 [1.70-6.39],0.0004049347601806
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),27060,78,3.51 [1.80-6.84],0.0002269324915787
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22598,1805,1.27 [1.09-1.49],0.0027890813723037
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22713,1776,1.27 [1.09-1.49],0.0029509517711465
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28115,96,1.96 [1.06-3.64],0.0331244751805407
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",27041,59,2.56 [1.16-5.65],0.0194705481268679
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Bronchiectasis,25295,186,1.98 [1.25-3.14],0.0036678974758894
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27524,2415,1.43 [1.25-1.63],9.04476234641878e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28300,732,2.43 [1.97-3.00],1.3957278937532056e-16
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26448,4376,1.49 [1.35-1.64],1.6814909245803353e-15
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,28082,514,2.86 [2.24-3.65],2.586128735209693e-17
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Emphysema,25299,190,2.41 [1.63-3.54],8.571991302744477e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27129,116,2.78 [1.58-4.91],0.0004013071183593
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28218,1236,2.16 [1.81-2.56],3.7313026062738064e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,27154,141,2.89 [1.73-4.83],5.235243637583162e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Later onset COPD,26936,218,1.68 [1.13-2.50],0.0108769815564213
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28398,160,2.82 [1.78-4.47],1.0514150126573156e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28194,631,2.06 [1.61-2.64],8.697965235536892e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,28230,1280,2.08 [1.76-2.47],2.9775649159605506e-17
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27739,912,1.29 [1.04-1.60],0.0222096070220801
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other pleural conditions,26984,34,2.94 [1.04-8.34],0.0427244833293437
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28354,203,2.88 [1.91-4.35],5.110220468245785e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28323,872,1.86 [1.51-2.29],5.344544735437949e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,27559,609,2.66 [2.09-3.38],1.867995312701364e-15
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",28005,1023,2.09 [1.72-2.52],4.2183471260752213e-14
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28378,140,2.53 [1.54-4.15],0.000245033670326
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pneumothorax,27015,65,3.07 [1.49-6.32],0.0023908422272883
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pulmonary oedema,28189,38,5.53 [2.46-12.44],3.591123608637177e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20975,38,3.35 [1.28-8.76],0.013795131042657
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28174,611,2.17 [1.70-2.79],9.658537220766712e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Viral pneumonia,27179,197,1.80 [1.16-2.81],0.0090899938796235
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28137,170,1.86 [1.16-2.98],0.0098827722949572
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16434,102,2.35 [1.23-4.49],0.0096162674838273
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,26769,170,2.63 [1.66-4.17],3.8762597297921205e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute peritonitis,27957,75,3.56 [1.83-6.93],0.0001879714725534
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27610,87,26.76 [18.68-38.34],7.340057620222875e-72
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Barrett oesophagus,22978,358,1.81 [1.29-2.53],0.0005725282225767
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26657,58,2.99 [1.38-6.45],0.0053564112818525
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27984,58,2.95 [1.35-6.46],0.0067988643042517
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,26782,183,2.07 [1.31-3.27],0.0018362434068674
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,27532,933,1.61 [1.31-1.98],8.183018538077604e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,22884,264,2.67 [1.83-3.90],3.6421174369798323e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26643,44,6.61 [3.30-13.24],1.0053874435324517e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28254,81,22.44 [14.68-34.29],8.130808218958989e-47
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,26937,121,7.36 [4.52-11.99],1.0602703780231989e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,28179,1201,1.53 [1.28-1.85],5.85138773434387e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,26833,97,3.16 [1.72-5.81],0.0002129673879969
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28046,68,2.59 [1.23-5.43],0.0119772356884518
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26831,95,3.15 [1.70-5.84],0.0002744182999422
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,27540,270,2.09 [1.44-3.04],0.0001062644589042
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26287,1883,1.43 [1.23-1.66],3.572327960464243e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,28285,762,4.98 [4.07-6.10],9.053569869848963e-55
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26650,4030,1.50 [1.36-1.67],5.9108699607682706e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27902,632,2.07 [1.61-2.64],8.746385176720454e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28325,443,2.11 [1.57-2.84],8.148498199544358e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27402,132,1.74 [1.01-3.00],0.046932363948356
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28122,1306,1.77 [1.48-2.11],2.1174603437797288e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27872,1273,1.84 [1.54-2.20],1.1141087050289192e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24198,2505,1.35 [1.18-1.53],8.19699111881425e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,22768,148,3.27 [2.03-5.27],1.14540793349117e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28335,117,4.47 [2.71-7.37],4.180527062177493e-09
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27626,103,17.98 [11.93-27.11],2.653304371273824e-43
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,22906,286,1.85 [1.28-2.68],0.001046594845383
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24934,2314,1.40 [1.22-1.60],1.28113381945567e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23034,414,2.08 [1.53-2.81],2.320377455992332e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23195,8307,1.32 [1.23-1.42],8.675976862062592e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,27867,1051,1.49 [1.22-1.81],8.99323498926273e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27334,64,3.18 [1.56-6.48],0.0014092140744001
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22646,1328,1.50 [1.25-1.79],1.3840845016945647e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27580,57,8.76 [4.55-16.88],8.654742695657053e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,27220,2816,1.28 [1.13-1.45],7.149726097280279e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21768,75,2.09 [1.01-4.33],0.0479326269643248
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26957,141,6.03 [3.79-9.61],4.0075628610234166e-14
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22283,590,1.81 [1.38-2.37],1.6214076353266623e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28383,399,4.97 [3.77-6.56],7.260695152407235e-30
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27453,717,1.66 [1.30-2.11],3.564239256610719e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27643,907,1.60 [1.29-1.98],1.7479660472399435e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22775,155,2.39 [1.47-3.89],0.0004563257515644
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,23123,503,2.22 [1.68-2.93],1.617996801191006e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,23024,1331,1.42 [1.18-1.70],0.0001392983673089
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26801,202,1.95 [1.26-3.02],0.0026170560305073
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,23236,1543,1.54 [1.31-1.82],2.856440262430071e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,26720,5027,1.38 [1.25-1.51],1.2781375407088764e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,28139,616,4.81 [3.83-6.04],1.8136791833963816e-41
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23171,551,1.97 [1.51-2.58],7.602652213531671e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26687,88,2.88 [1.56-5.31],0.0007214419140978
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28267,385,1.94 [1.40-2.67],5.570398940640109e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23422,802,2.25 [1.80-2.81],9.811666423498737e-13
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27881,1065,1.49 [1.22-1.81],7.403904025494074e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27465,195,2.04 [1.31-3.19],0.0016426270628446
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22943,1250,1.66 [1.38-1.99],5.663683847502749e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24466,1846,1.97 [1.70-2.28],1.6612007669551798e-19
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27607,84,11.16 [6.58-18.93],3.435295203887629e-19
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27530,794,1.64 [1.31-2.06],1.9261374933036245e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21931,238,1.99 [1.32-3.01],0.0010073674288931
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,22052,359,1.91 [1.37-2.68],0.0001596432746764
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26958,142,2.19 [1.31-3.68],0.002820004114536
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28398,61,2.89 [1.32-6.32],0.0076882190483576
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27288,133,2.73 [1.61-4.64],0.0001935417539891
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22814,194,2.46 [1.60-3.79],4.547069079468876e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21797,104,2.27 [1.26-4.12],0.0066130961096193
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,24630,226,2.29 [1.52-3.45],7.409264945877682e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28126,77,5.09 [2.73-9.50],3.259646862543564e-07
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27765,574,1.38 [1.06-1.79],0.0160960767021802
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26909,180,4.37 [2.92-6.56],9.66278290009739e-13
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28138,232,1.95 [1.29-2.95],0.0016611805520164
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28308,402,2.33 [1.71-3.16],7.366849627536037e-08
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27955,49,4.86 [2.11-11.20],0.0002110924593461
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26906,2662,1.55 [1.36-1.75],9.103220791524542e-12
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,28010,819,1.30 [1.04-1.62],0.0214123315260343
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28394,48,3.24 [1.33-7.90],0.0098748969114344
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26787,58,6.01 [2.96-12.20],7.143705871091321e-07
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27518,41,2.76 [1.06-7.21],0.0380908178013013
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28132,226,1.89 [1.23-2.88],0.0033359986616878
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27333,142,1.82 [1.08-3.07],0.0241102689228435
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28212,163,2.61 [1.63-4.18],6.227713304450811e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27939,33,3.35 [1.25-9.01],0.0163560591504111
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27869,1140,1.70 [1.40-2.05],4.579393687284536e-08
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28323,274,3.24 [2.26-4.62],1.1108631281705736e-10
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27970,64,3.70 [1.82-7.55],0.0003159272283315
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28274,225,3.26 [2.21-4.81],2.5851032857171633e-09
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26866,137,2.75 [1.66-4.54],8.239407865347474e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24942,138,2.55 [1.50-4.35],0.0005488387776707
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26528,4782,1.20 [1.09-1.32],0.0001296300888525
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25127,3381,1.14 [1.02-1.27],0.0258862610587817
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25497,155,1.70 [1.02-2.84],0.0428425973029314
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25507,165,1.82 [1.10-3.00],0.018879973796558
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25389,47,2.73 [1.10-6.77],0.0307367548024482
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25644,302,1.78 [1.22-2.59],0.0025253174192303
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24855,6430,1.19 [1.09-1.29],6.307263479691326e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24921,117,1.88 [1.06-3.34],0.0301194627036873
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27494,2152,1.36 [1.19-1.57],1.4125618292505456e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25034,230,1.59 [1.04-2.44],0.0322378829968593
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25098,294,1.83 [1.25-2.67],0.0018034482017882
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22154,408,1.50 [1.10-2.05],0.0111913521494497
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28352,398,1.56 [1.14-2.13],0.0053355845350774
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25909,567,1.44 [1.10-1.89],0.0086390847105045
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24893,89,3.28 [1.74-6.18],0.0002411679552721
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26948,58,3.55 [1.66-7.57],0.0010706677985581
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,28067,1177,2.12 [1.76-2.55],1.2979029519646933e-15
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27556,666,2.48 [1.95-3.16],1.7065648910066382e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28296,357,2.31 [1.67-3.20],4.922989521983121e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23566,1820,1.30 [1.11-1.52],0.0008328153230457
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27140,250,3.19 [2.17-4.70],4.405705170486629e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28364,87,2.51 [1.32-4.78],0.0052128813949611
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26945,1603,1.34 [1.14-1.58],0.0003626476647515
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25992,650,1.63 [1.27-2.10],0.0001458911767285
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28381,73,4.76 [2.49-9.09],2.2422141676380603e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25941,1137,1.47 [1.21-1.78],8.762942893291471e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22887,1141,1.51 [1.25-1.84],2.23311500028569e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25220,416,1.73 [1.27-2.36],0.0004851511160012
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28056,216,3.40 [2.26-5.11],3.9792940282325344e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25821,479,2.02 [1.52-2.69],1.470502423218905e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28305,337,2.52 [1.81-3.51],4.7461406841442134e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22799,610,1.71 [1.31-2.21],5.954250045502881e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24977,173,2.30 [1.43-3.68],0.0005631539731232
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23553,1807,1.54 [1.33-1.80],1.894322243805332e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22206,460,1.47 [1.08-1.99],0.0133858768025541
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27927,87,2.63 [1.37-5.04],0.0036285802012214
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28329,52,3.51 [1.59-7.77],0.0019083608171592
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21821,75,5.02 [2.61-9.66],1.3006166321483537e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22107,361,2.37 [1.70-3.32],4.4423124702771314e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27931,91,5.28 [2.92-9.54],3.5654788104262856e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27287,2483,1.24 [1.08-1.41],0.001575721350263
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25704,362,1.90 [1.36-2.65],0.0001611234320749
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25498,156,1.78 [1.06-2.99],0.0279475050279429
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26427,1085,1.66 [1.37-2.01],3.1816066548052657e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,26066,724,1.71 [1.35-2.17],8.525897458647298e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27989,149,4.26 [2.64-6.88],2.764882251210705e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21784,38,3.13 [1.17-8.35],0.0227921490590811
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27829,881,2.80 [2.29-3.41],2.8400522581882693e-24
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28102,332,1.50 [1.06-2.12],0.0210557358477698
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27663,715,2.41 [1.93-3.03],2.4187386604342275e-14
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,26123,167,1.76 [1.07-2.89],0.0248830476023639
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dialysis,27009,61,3.04 [1.44-6.41],0.0034794476613301
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23960,4403,1.44 [1.31-1.59],3.371830508155901e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28252,71,4.07 [2.07-7.98],4.604597499494963e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26862,236,1.54 [1.01-2.33],0.0435739060291907
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11771,302,1.63 [1.10-2.40],0.0138590018783828
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12925,1456,1.22 [1.02-1.46],0.0304989338337729
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27517,1561,1.57 [1.34-1.85],4.143873905252754e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28356,323,1.78 [1.26-2.52],0.0010389251039084
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11176,75,0.47 [0.26-0.85],0.0130463100900465
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28368,54,2.34 [1.00-5.47],0.049078109940779
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27085,1129,1.91 [1.58-2.30],1.6519729483894183e-11
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11530,61,2.62 [1.16-5.94],0.0208535381818263
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11578,109,1.93 [1.03-3.60],0.0395280730210287
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26897,271,1.50 [1.02-2.22],0.0413069945596186
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28200,1574,2.37 [2.04-2.77],2.1855053651881284e-28
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26773,147,3.54 [2.16-5.81],5.761635726836758e-07
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27028,80,2.09 [1.06-4.10],0.0333454969958154
